Review Article

The Current Evidence Levels for Biofeedback and Neurofeedback Interventions in Treating Depression: A Narrative Review

Table 6

Summary of the studies in rt-fMRI neurofeedback.

ArticleSampleDemonstrates efficacyOutcome measuresStatistical powerControl groupMultiple studiesRandomizationSuperior to NT, PLA, or ATNoninferior to TAUInclusion criteriaTreatment proceduresData analysis2+ independent studiesSuperiority to PLA or AT

Required for level122334444445
Major depressive disorder (MDD)
Linden et al. [152] (positive↑)
YC, MY/NYYYYYYY
Takamura et al. [153] (L DLPFC↑)YC, P1Y/NYYY
Young et al., [147] (L amygdala↑)
YMYYYYYYY
Young et al. [150] (L amygdala↑)
YC, P1YYYYYYYY
Young et al. [148] (L amygdala↑)
YCogYYYYYYYY
Zotev et al. [151] (L ACC, L amygdala↑, FαA, FβA)
YMYYYYYYY
Hamilton et al. [154] (salience network↓)
YCogYYYYYYY
Depressive disorders other than MDD
Mehler et al. [36] (positive↑)
YC, P1YYYY/NYYY
Quevedo et al. [146] (amygdala+hippocampus↑)YCogYYYY

EG: sample size of the experimental group; CG: sample size of the control group; NT: no treatment; PLA: placebo intervention; AT: alternative treatment; TAU: treatment as usual; Y: yes (criterion fulfilled); Y/N: yes/no (criterion partly fulfilled); C: clinical outcome measure; P1: well-established subjective test of depression; M: test of mood; Cog: cognitive feature of depression; Positive: individual regions of interest active while positive vs. neutral stimuli observed; L: left; DLPFC: dorsolateral prefrontal cortex; ACC: anterior cingulate cortex; FαA, FβA: EEG frontal alpha/beta asymmetry; ↑: upregulation; ↓: downregulation.